Spotlight Asset Group »

Abvc Biopharma shares owned by Spotlight Asset Group

Quarter-by-quarter ownership of Abvc Biopharma (ABVC) shares owned by Spotlight Asset Group from 13F filings

Historical chart of Spotlight Asset Group investment in Abvc Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Abvc Biopharma held by Spotlight Asset Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abvc Biopharma by Spotlight Asset Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $104 100 1.04
2023-09-30 $104 100 1.04

More positions owned by Spotlight Asset Group

Apple Stock (AAPL)
Ishares Core S&p 500 Etf Etf (IVV)
Aptus Collared Investment Opportunity Etf Etf (ACIO)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)
Meta Platforms Inc Cl A Stock (META)
Ishares S&p 500 Value Etf Etf (IVE)
Ishares Msci Eafe Etf Etf (EFA)
Opus Small Cap Value Etf Etf (OSCV)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Vanguard Growth Etf Etf (VUG)
Amazon Stock (AMZN)
Aptus Enhanced Yield Etf Etf (JUCY)
Gilead Sciences Stock (GILD)
Microsoft Corp Stock (MSFT)
Ishares 7-10 Year Treasury Bond Etf Etf (IEF)

View all positions for Spotlight Asset Group

Top funds holding Abvc Biopharma

Chase Investment Counsel Corp.
Vanguard Group
Citadel Advisors
Spotlight Asset Group
Royal Bank of Canada
Wells Fargo & Company

View all funds holding Abvc Biopharma